NASDAQ:XCUR Exicure (XCUR) Stock Forecast, Price & News $0.75 0.00 (0.00%) (As of 09/22/2023 ET) Add Compare Share Share Today's Range$0.72▼$0.8150-Day Range$0.74▼$1.3052-Week Range$0.63▼$1.96Volume6,114 shsAverage Volume16,627 shsMarket Capitalization$6.50 millionP/E Ratio0.45Dividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainabilityProfileChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability About Exicure (NASDAQ:XCUR) StockExicure, Inc., an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.Read More XCUR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XCUR Stock News HeadlinesSeptember 19, 2023 | americanbankingnews.comExicure (NASDAQ:XCUR) Trading Down 12.1%August 29, 2023 | finance.yahoo.comLacklustre Performance Is Driving Exicure, Inc.'s (NASDAQ:XCUR) 25% Price DropSeptember 24, 2023 | Legacy Research (Ad)WARNING: Mandatory U.S. Dollar Recall is Weeks AwayIf you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars.August 23, 2023 | msn.comExicure names new CEO, CFO, directors in wake of resignationsAugust 15, 2023 | finance.yahoo.comExicure First Half 2023 Earnings: US$1.38 loss per share (vs US$3.71 loss in 1H 2022)August 11, 2023 | marketwatch.comExicure: Substantial Financing Needed to Continue OperationsAugust 11, 2023 | businesswire.comExicure, Inc. Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateJuly 14, 2023 | finance.yahoo.comExicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate UpdateSeptember 24, 2023 | Legacy Research (Ad)Watch SHOCKING Footage of AI Facility with Ties to Elon MuskI recently traveled more than 3,000 miles and shot this video outside what could end up being Elon Musk’s biggest secret. Most people don’t know about this facility, but it could be the most important AI project in the world. What’s happening inside these walls is so important that our government has declared it a matter of national security.May 26, 2023 | msn.comExicure board backs CEO Kim's strategic alternative view for companyMay 26, 2023 | finance.yahoo.comExicure, Inc. Announces Support of CEO in its Ongoing Exploration of Strategic AlternativesMay 25, 2023 | sg.finance.yahoo.comExicure, Inc. (XCUR) stock price, news, quote & history – Yahoo FinanceMay 19, 2023 | seekingalpha.comExicure gets Nasdaq non-compliance notice for not filing 10-QApril 27, 2023 | finance.yahoo.comExicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of DirectorsMarch 28, 2023 | wsj.comExicure Warns of Need to Raise Additional Funds to Keep OperatingMarch 28, 2023 | finance.yahoo.comExicure, Inc. Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 20, 2023 | investing.comExicure (XCUR) Earnings Dates & ReportsJanuary 15, 2023 | finance.yahoo.comExicure, Inc. (XCUR) Stock Historical Prices & Data - Yahoo FinanceNovember 15, 2022 | marketwatch.comExicure Warns of Needing Bankruptcy Protection if Deal with CBI USA FailsNovember 15, 2022 | ca.finance.yahoo.comExicure, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateSeptember 28, 2022 | finance.yahoo.comExicure Lays Off Two-Third Employees, Ceases R&D ActivitiesSeptember 27, 2022 | uk.investing.comJabil, TD Synnex And 3 Stocks To Watch Heading Into Tuesday By Benzinga - Investing.com UKSeptember 26, 2022 | benzinga.comExicure shares are trading higher after the company announced a workforce reduction and a private placeme - BenzingaSeptember 26, 2022 | investing.comAfter-Hours Movers: Nautilus Gains on Strategic Review By Investing.com - Investing.comSeptember 26, 2022 | seekingalpha.comExicure to get $5.4M equity financing, reduce workforce & end R&D, preclinical activities - Seeking AlphaSeptember 26, 2022 | businesswire.comExicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces Implementation of Strategic Measure to Reduce Cash Burn and Prioritize Strategic Alternatives - Business WireSeptember 25, 2022 | reuters.comXCUR.N - Exicure Inc | Stock Price & Latest News | ReutersSee More Headlines Receive XCUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter. Email Address XCUR Company Calendar Last Earnings8/11/2023Today9/24/2023Next Earnings (Estimated)11/13/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:XCUR CUSIPN/A CIK1698530 Webwww.exicuretx.com Phone(847) 673-1700FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.68 Trailing P/E Ratio0.45 Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,580,000.00 Net Margins-8.96% Pretax Margin13.76% Return on Equity34.49% Return on Assets13.07% Debt Debt-to-Equity RatioN/A Current Ratio2.56 Quick Ratio2.56 Sales & Book Value Annual Sales$28.83 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$3.00 per share Price / Book0.25Miscellaneous Outstanding Shares8,650,000Free Float8,311,000Market Cap$6.50 million OptionableNot Optionable Beta1.31 Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Paul Kang (Age 61)CEO & Director Ms. Jiyoung Hwang (Age 46)CFO & Director Mr. Joshua Miller (Age 47)Chief Accounting Officer Mr. Bart AndersonSr. Director of R&DKey CompetitorsBiophytisNASDAQ:BPTSPaxMedicaNASDAQ:PXMDGRI BioNASDAQ:GRISeaStar MedicalNASDAQ:ICUFresh Tracks TherapeuticsNASDAQ:FRTXView All CompetitorsInsiders & InstitutionsCitadel Advisors LLCBought 50,354 shares on 8/15/2023Ownership: 0.582%Carlson Capital L PSold 64,100 shares on 8/10/2023Ownership: 1.445%Cbi Usa, Inc.Bought 3,400,000 shares on 12/15/2022Total: $5.44 M ($1.60/share)View All Insider TransactionsView All Institutional Transactions XCUR Stock - Frequently Asked Questions How have XCUR shares performed in 2023? Exicure's stock was trading at $1.15 at the beginning of the year. Since then, XCUR stock has decreased by 34.7% and is now trading at $0.7510. View the best growth stocks for 2023 here. When is Exicure's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023. View our XCUR earnings forecast. How were Exicure's earnings last quarter? Exicure, Inc. (NASDAQ:XCUR) announced its quarterly earnings results on Friday, August, 11th. The company reported ($0.68) earnings per share for the quarter. Exicure had a positive trailing twelve-month return on equity of 34.49% and a negative net margin of 8.96%. When did Exicure's stock split? Exicure shares reverse split on the morning of Thursday, June 30th 2022. The 1-30 reverse split was announced on Thursday, June 30th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 30th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. What is Exicure's stock symbol? Exicure trades on the NASDAQ under the ticker symbol "XCUR." Who are Exicure's major shareholders? Exicure's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Carlson Capital L P (1.45%) and Citadel Advisors LLC (0.58%). Insiders that own company stock include Bali Muralidhar, Cbi Usa, Inc, Elias D Papadimas and Gates Frontier, Llc. View institutional ownership trends. How do I buy shares of Exicure? Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Exicure's stock price today? One share of XCUR stock can currently be purchased for approximately $0.75. How much money does Exicure make? Exicure (NASDAQ:XCUR) has a market capitalization of $6.50 million and generates $28.83 million in revenue each year. The company earns $-2,580,000.00 in net income (profit) each year or $1.68 on an earnings per share basis. How can I contact Exicure? Exicure's mailing address is 2430 N. Halsted St., Chicago IL, 60614. The official website for the company is www.exicuretx.com. The company can be reached via phone at (847) 673-1700 or via email at ir@exicuretx.com. This page (NASDAQ:XCUR) was last updated on 9/24/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exicure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.